Pharma Industry News

bluebird bio’s sickle cell gene therapy granted MHRA ‘innovation passport’

Innovation passport designation scheme aims to reduce the time to market for promising treatmentsOriginal Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]